Roger S McIntyre Selected Research

Bipolar Disorder (Manic Depressive Psychosis)

6/2022	Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: A Systematic Review and Recommendations of Cannabis use in Bipolar Disorder and Major Depressive Disorder.
2/2022	The efficacy of cariprazine on cognition: a post hoc analysis from phase II/III clinical trials in bipolar mania, bipolar depression, and schizophrenia.
1/2022	Lumateperone for the Treatment of Adults With Schizophrenia: a Systematic Review.
1/2022	Pre-treatment Pain Symptoms Influence Antidepressant Response to Ketamine in Depressive Patients.
1/2022	Olanzapine and samidorphan combination treatment: A systematic review.
1/2022	Does body mass index predict response to intravenous ketamine treatment in adults with major depressive and bipolar disorder? Results from the Canadian Rapid Treatment Center of Excellence.
1/2022	What not to use in bipolar disorders: A systematic review of non-recommended treatments in clinical practice guidelines.
1/2022	Long-term outcomes of repeated ketamine infusions in patients with unipolar and bipolar depression: A naturalistic follow-up study.
1/2022	Prevalence of type 2 diabetes mellitus, impaired fasting glucose, general obesity, and abdominal obesity in patients with bipolar disorder: A systematic review and meta-analysis.
12/2021	The potential pro-cognitive effects with intravenous subanesthetic ketamine in adults with treatment-resistant major depressive or bipolar disorders and suicidality.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roger S McIntyre Research Topics

Disease

127	Bipolar Disorder (Manic Depressive Psychosis) 06/2022 - 01/2002
120	Major Depressive Disorder (Major Depressive Disorders) 06/2022 - 04/2005
53	Mood Disorders (Mood Disorder) 01/2022 - 02/2006
39	Treatment-Resistant Depressive Disorder 07/2022 - 01/2019
39	Mania (Manias) 02/2022 - 03/2004
35	Mental Disorders (Mental Disorder) 07/2022 - 07/2006
33	Schizophrenia (Dementia Praecox) 02/2022 - 11/2003
32	Obesity 01/2022 - 04/2005
30	Inflammation (Inflammations) 04/2021 - 01/2007
26	Cognitive Dysfunction 02/2022 - 01/2013
25	Weight Gain 01/2022 - 01/2002
16	Anhedonia 07/2022 - 11/2015
16	Type 2 Diabetes Mellitus (MODY) 01/2022 - 10/2008
16	Insulin Resistance 10/2021 - 01/2006
13	Depressive Disorder (Melancholia) 01/2022 - 11/2002
13	Sleepiness 01/2019 - 01/2002
12	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2022 - 02/2009
12	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2020 - 02/2003
11	Cardiovascular Diseases (Cardiovascular Disease) 05/2022 - 08/2010
11	Psychomotor Agitation (Akathisia) 01/2022 - 10/2005
11	Hypertension (High Blood Pressure) 11/2021 - 08/2007
10	Substance-Related Disorders (Drug Abuse) 06/2022 - 09/2007
10	Diabetes Mellitus 05/2022 - 01/2002
9	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 01/2007
9	Weight Loss (Weight Reduction) 01/2021 - 01/2002
8	Overweight 01/2021 - 04/2005
8	Dyslipidemias (Dyslipidemia) 01/2020 - 06/2008
8	Body Weight (Weight, Body) 01/2018 - 02/2003
7	Anxiety Disorders (Anxiety Disorder) 01/2022 - 11/2014
7	Pain (Aches) 01/2022 - 03/2004
7	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 08/2007
6	Neurobehavioral Manifestations 02/2022 - 08/2015
6	COVID-19 01/2022 - 01/2020
5	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022 - 11/2010
5	Tardive Dyskinesia 12/2021 - 01/2002
4	Alcoholism (Alcohol Abuse) 01/2022 - 09/2007
4	Nausea 01/2021 - 01/2010
4	Migraine Disorders (Migraine) 01/2020 - 06/2006

Drug/Important Bio-Agent (IBA)

111	Antidepressive Agents (Antidepressants)IBA 01/2022 - 01/2002
52	Ketamine FDA LinkGeneric 07/2022 - 11/2013
47	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 01/2002
19	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 05/2022 - 12/2007
19	Insulin (Novolin)FDA Link 01/2021 - 08/2007
19	Quetiapine Fumarate (Seroquel)FDA Link 01/2019 - 11/2003
18	Olanzapine (Zyprexa)FDA Link 01/2022 - 08/2003
17	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 04/2005
17	Biological ProductsIBA 12/2021 - 01/2007
16	Biomarkers (Surrogate Marker)IBA 05/2022 - 11/2006
16	VortioxetineIBA 01/2022 - 10/2014
15	CytokinesIBA 01/2022 - 08/2009
15	LithiumIBA 01/2022 - 02/2003
12	Pharmaceutical PreparationsIBA 07/2022 - 02/2006
12	Valproic Acid (Depakote)FDA LinkGeneric 01/2022 - 01/2002
12	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2022 - 08/2003
12	Aripiprazole (Abilify)FDA Link 01/2022 - 05/2007
12	asenapine FDA Link 12/2021 - 11/2009
10	Bupropion (Wellbutrin)FDA LinkGeneric 01/2021 - 06/2002
10	C-Reactive ProteinIBA 11/2020 - 08/2009
10	Serotonin (5 Hydroxytryptamine)IBA 09/2020 - 06/2007
9	EsketamineIBA 06/2022 - 01/2020
9	cariprazineIBA 02/2022 - 01/2018
9	Brain-Derived Neurotrophic Factor (BDNF)IBA 11/2021 - 10/2009
9	Infliximab (Remicade)FDA Link 01/2021 - 12/2018
8	Lamotrigine (Lamictal)FDA LinkGeneric 01/2022 - 01/2002
8	Interleukin-6 (Interleukin 6)IBA 01/2022 - 04/2015
8	Norepinephrine (Noradrenaline)FDA LinkGeneric 12/2019 - 06/2007
8	Anticonvulsants (Antiepileptic Drugs)IBA 11/2018 - 01/2002
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 08/2009
6	ziprasidone (Geodon)FDA Link 01/2022 - 08/2007
6	Nerve Growth Factors (Neurotrophins)IBA 10/2021 - 11/2012
6	Tryptophan (L-Tryptophan)FDA Link 02/2021 - 06/2014
6	CholesterolIBA 09/2020 - 07/2006
6	Fluoxetine (Prozac)FDA LinkGeneric 05/2020 - 01/2006
6	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2019 - 08/2009
6	Methylphenidate (Ritalin)FDA LinkGeneric 03/2018 - 11/2014
5	Topiramate (Topamax)FDA LinkGeneric 01/2022 - 01/2002
5	EnzymesIBA 02/2021 - 01/2016
5	KynurenineIBA 01/2021 - 06/2014
5	Triglycerides (Triacylglycerol)IBA 01/2021 - 07/2006
5	Carbamazepine (Tegretol)FDA LinkGeneric 12/2020 - 01/2002
5	LeptinIBA 10/2020 - 08/2003
5	Dopamine (Intropin)FDA LinkGeneric 09/2020 - 06/2007
5	Neurotransmitter Agents (Neurotransmitter)IBA 07/2020 - 11/2010
5	AdiponectinIBA 01/2020 - 12/2014
5	Serotonin and Noradrenaline Reuptake InhibitorsIBA 12/2019 - 01/2010
5	Glutamic Acid (Glutamate)FDA Link 01/2019 - 06/2007
5	Desvenlafaxine Succinate FDA Link 05/2016 - 07/2014
5	GlucocorticoidsIBA 01/2014 - 06/2007
4	Psilocybin (Psilocibin)IBA 01/2022 - 12/2020
4	ProlactinIBA 01/2022 - 02/2003
4	Therapeutic UsesIBA 01/2022 - 01/2020
4	AntioxidantsIBA 01/2022 - 11/2013
4	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2006
4	brexpiprazoleIBA 12/2021 - 09/2016
4	Testosterone (Sustanon)FDA Link 01/2021 - 02/2003
4	Hormones (Hormone)IBA 01/2020 - 06/2011
4	Hypoglycemic Agents (Hypoglycemics)IBA 12/2019 - 07/2006

Therapy/Procedure

36	Therapeutics 01/2022 - 06/2002
22	Drug Therapy (Chemotherapy) 12/2021 - 01/2005
5	Bariatric Surgery 01/2019 - 05/2011